Taking on the task of building the most comprehensive platform to develop innovative microbiome therapeutics, (The) BioCollective LLC is structured as a direct-to-consumer personal health and wellness platform having the microbiome at its core. Serving both commercial biotechnology and consumers, the firm recruits users (members) to provide feces samples that are leveraged across many research platforms. Collect the entire stool along with rich meta data from our members and metagenomic data from the sample, the firm have developed the BioFlux Metabolomic Model for in silico product development or existing product/drug/chemical impact testing on the metabolic output of the microbiome. The "most wanted" microbes are targeted for isolation and culture -- currently curating a collection of bespoke microbes from diverse sources, including the deep sea. The firm then undertatkes shotgun metagenomics and to build a unique data set to enable personalize medicine by bringing rich CONTEXT to the samples. This approach has permited very quickly tthe identification of targets and development of groundbreaking probiotics to restore the internal pharmacy.